BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wibowo D, Jorritsma SHT, Gonzaga ZJ, Evert B, Chen S, Rehm BHA. Polymeric nanoparticle vaccines to combat emerging and pandemic threats. Biomaterials 2021;268:120597. [PMID: 33360074 DOI: 10.1016/j.biomaterials.2020.120597] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Patil V, Hernandez-franco JF, Hogenesch H, Renukaradhya GJ. Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives. Front Immunol 2022;13:858321. [DOI: 10.3389/fimmu.2022.858321] [Reference Citation Analysis]
2 Gao Y, Gong X, Yu S, Jin Z, Ruan Q, Zhang C, Zhao K. Immune enhancement of N-2-Hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nanoparticles vaccine. Int J Biol Macromol 2022;220:183-92. [PMID: 35981671 DOI: 10.1016/j.ijbiomac.2022.08.073] [Reference Citation Analysis]
3 Weiss AM, Hossainy S, Rowan SJ, Hubbell JA, Esser-kahn AP. Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems. Macromolecules. [DOI: 10.1021/acs.macromol.2c00854] [Reference Citation Analysis]
4 Davodabadi F, Sarhadi M, Arabpour J, Sargazi S, Rahdar A, Díez-Pascual AM. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches. J Control Release 2022;349:844-75. [PMID: 35908621 DOI: 10.1016/j.jconrel.2022.07.036] [Reference Citation Analysis]
5 Liu SY, Qu HT, Sun RJ, Yuan D, Sui XH, Shan NN. High-throughput DNA methylation analysis in ITP confirms NOTCH1 hypermethylation through the Th1 and Th2 cell differentiation pathways. Int Immunopharmacol 2022;111:109105. [PMID: 35930913 DOI: 10.1016/j.intimp.2022.109105] [Reference Citation Analysis]
6 Wang C, Zhang J, Li B, Zuo J, Li Y, Sun Y, Wang F, Liu K, Li J. High-Efficiency Treatment for Osteoarthritis via Self-Assembled Dual-Functionalized Nanobiologics. ACS Biomater Sci Eng 2022. [PMID: 35801691 DOI: 10.1021/acsbiomaterials.2c00332] [Reference Citation Analysis]
7 Yang Z, Hua L, Yang M, Li W, Ren Z, Zheng X, Chen H, Long Q, Bai H, Huang W, Ma Y. Polymerized porin as a novel delivery platform for coronavirus vaccine. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01469-8] [Reference Citation Analysis]
8 Arshad R, Sargazi S, Fatima I, Mobashar A, Rahdar A, Ajalli N, Kyzas GZ. Nanotechnology for Therapy of Zoonotic Diseases: A Comprehensive Overview. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Toraskar S, Madhukar Chaudhary P, Kikkeri R. The Shape of Nanostructures Encodes Immunomodulation of Carbohydrate Antigen and Vaccine Development. ACS Chem Biol 2022;17:1122-30. [PMID: 35426652 DOI: 10.1021/acschembio.1c00998] [Reference Citation Analysis]
10 Ghaemmaghamian Z, Zarghami R, Walker G, O'Reilly E, Ziaee A. Stabilizing vaccines via drying: Quality by design considerations. Adv Drug Deliv Rev 2022;187:114313. [PMID: 35597307 DOI: 10.1016/j.addr.2022.114313] [Reference Citation Analysis]
11 De R, Song YH, Mahata MK, Lee KT. pH-responsive polyelectrolyte complexation on upconversion nanoparticles: a multifunctional nanocarrier for protection, delivery, and 3D-imaging of therapeutic protein. J Mater Chem B 2022;10:3420-33. [PMID: 35389393 DOI: 10.1039/d2tb00246a] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Gonzaga ZJC, Zhang J, Rehm BHA. Intranasal Delivery of Antigen-Coated Polymer Particles Protects against Pseudomonas aeruginosa Infection. ACS Infect Dis 2022;8:744-56. [PMID: 35238554 DOI: 10.1021/acsinfecdis.1c00434] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cano-Vicent A, Hashimoto R, Takayama K, Serrano-Aroca Á. Biocompatible Films of Calcium Alginate Inactivate Enveloped Viruses Such as SARS-CoV-2. Polymers (Basel) 2022;14:1483. [PMID: 35406356 DOI: 10.3390/polym14071483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Lima MRN, Devore DI, Kohn J. Nanosphere size control by varying the ratio of poly(ester amide) block copolymer blends. J Colloid Interface Sci 2022;623:247-56. [PMID: 35588632 DOI: 10.1016/j.jcis.2022.03.144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim HJ, Seo SK, Park HY. Physical and chemical advances of synthetic delivery vehicles to enhance mRNA vaccine efficacy. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.029] [Reference Citation Analysis]
16 Chen S, Evert B, Adeniyi A, Salla-Martret M, Lua LH, Ozberk V, Pandey M, Good MF, Suhrbier A, Halfmann P, Kawaoka Y, Rehm BHA. Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity. Adv Healthc Mater 2022;11:e2102089. [PMID: 34716678 DOI: 10.1002/adhm.202102089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Dong C, Wang Y, Zhu W, Ma Y, Kim J, Wei L, Gonzalez GX, Wang BZ. Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice. ACS Appl Mater Interfaces 2022. [PMID: 35084819 DOI: 10.1021/acsami.1c19192] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang X, Liu XY, Yang H, Chen JN, Lin Y, Han SY, Cao Q, Zeng HS, Ye JW. A Polyhydroxyalkanoates-Based Carrier Platform of Bioactive Substances for Therapeutic Applications. Front Bioeng Biotechnol 2021;9:798724. [PMID: 35071207 DOI: 10.3389/fbioe.2021.798724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Read BJ, Won L, Kraft JC, Sappington I, Aung A, Wu S, Bals J, Chen C, Lee KK, Lingwood D, King NP, Irvine DJ. Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens. Cell Rep 2022;38:110217. [PMID: 35021101 DOI: 10.1016/j.celrep.2021.110217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Han X, Alu A, Liu H, Shi Y, Wei X, Cai L, Wei Y. Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.01.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Goscianska J, Freund R, Wuttke S. Nanoscience versus Viruses: The SARS‐CoV‐2 Case. Adv Funct Materials 2022;32:2107826. [DOI: 10.1002/adfm.202107826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Dong C, Wang B. Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats. Advanced NanoBiomed Research 2022;2:2100122. [DOI: 10.1002/anbr.202100122] [Reference Citation Analysis]
23 Evert BJ, Chen S, McConville R, Steel RWJ, Healer J, Boddey JA, Huntimer L, Rehm BHA. Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites. NPJ Vaccines 2021;6:141. [PMID: 34845267 DOI: 10.1038/s41541-021-00408-2] [Reference Citation Analysis]
24 Gonzaga ZJC, Chen S, Lehoux M, Segura M, Rehm BHA. Engineering Antigens to Assemble into Polymer Particle Vaccines for Prevention of Streptococcus suis Infection. Vaccines (Basel) 2021;9:1386. [PMID: 34960132 DOI: 10.3390/vaccines9121386] [Reference Citation Analysis]
25 Meena J, Goswami DG, Anish C, Panda AK. Cellular uptake of polylactide particles induces size dependent cytoskeletal remodeling in antigen presenting cells. Biomater Sci 2021;9:7962-76. [PMID: 34704986 DOI: 10.1039/d1bm01312b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Constantin C, Pisani A, Bardi G, Neagu M. Nano-carriers of COVID-19 vaccines: the main pillars of efficacy. Nanomedicine (Lond) 2021;16:2377-87. [PMID: 34632802 DOI: 10.2217/nnm-2021-0250] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
27 Shahzamani K, Mahmoudian F, Ahangarzadeh S, Ranjbar MM, Beikmohammadi L, Bahrami S, Mohammadi E, Esfandyari S, Alibakhshi A, Javanmard SH. Vaccine design and delivery approaches for COVID-19. Int Immunopharmacol 2021;100:108086. [PMID: 34454291 DOI: 10.1016/j.intimp.2021.108086] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chen S, Quan DH, Wang XT, Sandford S, Kirman JR, Britton WJ, Rehm BHA. Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice. Nanomaterials (Basel) 2021;11:2060. [PMID: 34443891 DOI: 10.3390/nano11082060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Pan Y, Qi Y, Li X, Luan S, Huang Y. Application of Mannose‐Functionalized Microgel as a Novel Vaccine Delivery Platform for Subunit Vaccines. Adv Funct Materials 2021;31:2105742. [DOI: 10.1002/adfm.202105742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Gonzaga ZJC, Merakou C, DiGiandomenico A, Priebe GP, Rehm BHA. A Pseudomonas aeruginosa-Derived Particulate Vaccine Protects against P. aeruginosa Infection. Vaccines (Basel) 2021;9:803. [PMID: 34358220 DOI: 10.3390/vaccines9070803] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
31 Seyfoori A, Shokrollahi Barough M, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A, Madrakian T, Kiumarsi M, Walsh T, McAlinden KD, Ghosh CC, Sharma P, Zeki AA, Ghavami S, Akbari M. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID). Int J Mol Sci 2021;22:6937. [PMID: 34203268 DOI: 10.3390/ijms22136937] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
32 Pippa N, Gazouli M, Pispas S. Recent Advances and Future Perspectives in Polymer-Based Nanovaccines. Vaccines (Basel) 2021;9:558. [PMID: 34073648 DOI: 10.3390/vaccines9060558] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
33 Mallakpour S, Azadi E, Hussain CM. Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review. Int J Biol Macromol 2021;182:1931-40. [PMID: 34048834 DOI: 10.1016/j.ijbiomac.2021.05.155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wang F, Ullah A, Fan X, Xu Z, Zong R, Wang X, Chen G. Delivery of nanoparticle antigens to antigen-presenting cells: from extracellular specific targeting to intracellular responsive presentation. J Control Release 2021;333:107-28. [PMID: 33774119 DOI: 10.1016/j.jconrel.2021.03.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Emir Diltemiz S, Tavafoghi M, de Barros NR, Kanada M, Heinämäki J, Contag C, Seidlits SK, Ashammakhi N. Use of artificial cells as drug carriers. Mater Chem Front 2021;5:6672-92. [DOI: 10.1039/d1qm00717c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]